Abstract | BACKGROUND: SUBJECTS AND METHODS: To evaluate the efficacy of cyclosporin A (CsA) for AE of IPF, we conducted a retrospective study on autopsied IPF cases who developed AE and were treated with corticosteroids (CS) combined with CsA. The subjects comprised 11 males with a mean age of 69.9 years. The clinical features and prognosis of the CsA-treated group was compared to a group of 11 autopsied IPF cases with a mean age of 68.7 years who developed AE and were treated with CS alone (non-CsA-treated group). RESULTS: CS pulse therapy followed by CS maintenance treatment were conducted in all cases of AE. Patients in the CsA-treated group received in addition a low dosage of CsA (100-150 mg). Although 7 out of 11 patients in the CsA-treated group died of AE per se, 4 patients survived the AE. Only 2 patients died during the first episode of AE. In comparison, 7 out of 11 patients in the non-CsA-treated group died during the first episode of AE. The mean survival period after the first onset of AE was 285 days in the CsA-treated group and 60 days in the non-CsA-treated group. The prognosis of the CsA-treated group therefore was significantly better than that of non-CsA-treated group after AE of IPF. CONCLUSION: Administration of CsA combined with CS may be efficacious in the treatment of AE of IPF.
|
Authors | Susumu Sakamoto, Sakae Homma, Atsushi Miyamoto, Atsuko Kurosaki, Takeshi Fujii, Kunihiko Yoshimura |
Journal | Internal medicine (Tokyo, Japan)
(Intern Med)
Vol. 49
Issue 2
Pg. 109-15
( 2010)
ISSN: 1349-7235 [Electronic] Japan |
PMID | 20075573
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Acute Disease
- Aged
- Aged, 80 and over
- Cyclosporine
(therapeutic use)
- Disease Progression
- Female
- Humans
- Idiopathic Pulmonary Fibrosis
(drug therapy, mortality, pathology)
- Male
- Middle Aged
- Retrospective Studies
- Survival Rate
(trends)
- Treatment Outcome
|